Neuroendocrine Neoplasms, An Issue of PET Clinics

Cover image

Title page

Table of Contents

Copyright

Contributors

Forthcoming Issues

CME Accreditation Page

Erratum

Preface

Neuroendocrine Neoplasms: Epidemiology, Diagnosis, and Management

Key points

Introduction

Summary

Clinics care points

Neuroendocrine Neoplasms: Genetics and Epigenetics

Key points

Introduction

Defining the genomic and epigenomic landscape of neuroendocrine neoplasms

Summary

Clinics care points

Disclosure

Gastroenteropancreatic Neuroendocrine Tumor Diagnosis: DOTATATE PET/CT

Key points

Introduction

Summary

Clinics care points

Gastro-Enteric-Pancreatic Neuroendocrine Tumor Treatment: 177Lu-DOTATATE

Key points

Introduction

Eligibility criteria for 177Lu-DOTATATE therapy

Summary

Clinics care points

Disclosure

Gastro-Enteric-Pancreatic Neuroendocrine Tumor Treatment: Actinium-225-DOTATATE and Combined Therapies

Key points

Introduction

Clinics care points

Disclosure

Diagnosis and Treatment of Lung Neuroendocrine Neoplasms: Somatostatin Receptor PET Imaging and Peptide Receptor Radionuclide Therapy

Key points

Introduction

Summary

Clinics care points

Disclosure

Paragangliomas and Pheochromocytomas: Positron Emission Tomography/Computed Tomography Diagnosis and Therapy

Key points

Introduction

Summary

Clinics care points

Disclosure

Gastro-Entero-Pancreatic Tumors: FDG Positron Emission Tomography/Computed Tomography

Key points

Role of medical imaging in neuroendocrine neoplasms

Current state of 18F-FDG positron emission tomography/computed tomography in the diagnosis of gastro-entero-pancreatic neoplasms

Role of 18F FDG positron emission tomography/computed tomography in patient selection for peptide receptor radionuclide therapy and assessment of prognosis

Case presentations

Case discussion

Clinics care points

Disclosure

Neuroendocrine Neoplasms: Total-body PET/Computed Tomography

Key points

Introduction

Summary

Clinics care points

Disclosure

Funding

Neuroendocrine Tumor Diagnosis: PET/MR Imaging

Key points

Introduction

Somatostatin receptor-targeting PET/MR imaging

Somatostatin receptor-targeting PET/MR imaging for neuroendocrine tumor liver metastases

Fluorodeoxyglucose-PET/MR imaging

Challenges

Imaging protocols

Summary

Clinics care points

Neuroendocrine Tumor Therapy Response Assessment

Key points

Introduction

Future directions

Summary

Clinics care points